Equities

bluebird bio Inc

bluebird bio Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.4057
  • Today's Change0.024 / 6.18%
  • Shares traded5.98m
  • 1 Year change-87.56%
  • Beta0.7437
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, bluebird bio Inc increased its cash reserves by 73.31%, or 116.15m. Cash Flow from Financing totalled 196.25m or 665.32% of revenues. In addition the company used 235.05m for operations while cash from investing totalled 154.95m.
Cash flow per share-1.65
Price/Cash flow per share--
Book value per share0.2733
Tangible book value per share0.1925
More ▼

Balance sheet in USDView more

bluebird bio Inc has a Debt to Total Capital ratio of 78.27%.
Current ratio0.6831
Quick ratio0.5712
Total debt/total equity3.60
Total debt/total capital0.7827
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.